Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies

Summary Background & aims Previous epidemiological studies have provided inconsistent conclusions on the impact of coffee consumption in the developing of cognitive disorders. However, no previous meta-analysis has pooled the evidence from the prospective cohort studies to assess the influence o...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nutrition (Edinburgh, Scotland) Scotland), 2017-06, Vol.36 (3), p.730-736
Main Authors: Wu, Lei, Sun, Dali, He, Yao
Format: Article
Language:English
Subjects:
Alzheimer's disease
Coffee intake
Cognitive disorders
Cognitive impairment
Dementia
Gastroenterology and Hepatology
Meta-analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003
cites cdi_FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003
container_end_page 736
container_issue 3
container_start_page 730
container_title Clinical nutrition (Edinburgh, Scotland)
container_volume 36
creator Wu, Lei
Sun, Dali
He, Yao
description Summary Background & aims Previous epidemiological studies have provided inconsistent conclusions on the impact of coffee consumption in the developing of cognitive disorders. However, no previous meta-analysis has pooled the evidence from the prospective cohort studies to assess the influence of coffee drinking and its potential dose–response patterns on the risk of developing cognitive disorders specifically. Methods Two databases (PubMed and Embase) were searched for evidence of cohort studies from inception to February 2016. We used a generic inverse-variance method with a random-effects model to pool the fully adjusted relative risks (RRs) and the corresponding 95% confidence intervals (CIs). In the dose–response analyses, a generalized least-squares trend estimation model was applied to computing the study-specific slopes. Results Nine prospective cohort studies involving 34,282 participants were included in our study. The duration of follow-up years ranged from 1.3 to 28. Compared with
doi_str_mv 10.1016/j.clnu.2016.05.015
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826706778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S026156141630111X</els_id><sourcerecordid>1826706778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxoMo7rj6Ah4kRy_d5k93JyMiLMP6BxY8qOAtxKTazUxPMqbSC3MR38E39ElMO6sHD-ZSKfi-or5fEfKYs5YzPjzbtm6Kcyvqv2V9y3h_h6x4L0XD11reJSsmBt70A-_OyAPELWOsl0rfJ2dCCa2l0CvybZPGEYCGWOwOqI2eluuldcFDLDQH3NE0Upe-xFDCDVAfMGUPGZ_TC-oTws_vPzLgIUUEuodiGxvtdMSAiy-GCPSQEx7A_ba7dJ1yoVhmHwAfknujnRAe3dZz8vHV5YfNm-bq3eu3m4urxnVKlUaxWodRCblWQsGga287CWDt2iuAHpjurJCdkMvzHSjfs66HDnRNzeQ5eXqaW1f5OgMWsw_oYJpshDSj4VoMig1K6SoVJ6mrW2OG0Rxy2Nt8NJyZhbvZmoW7Wbgb1pvKvZqe3M6fP-_B_7X8AV0FL04CqClvAmSDLkB04EOuZIxP4f_zX_5jd1OIwdlpB0fAbZpzhV5zGBSGmffL5ZfD80Eyzvkn-Qvf_6sR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826706778</pqid></control><display><type>article</type><title>Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies</title><source>ScienceDirect Journals</source><creator>Wu, Lei ; Sun, Dali ; He, Yao</creator><creatorcontrib>Wu, Lei ; Sun, Dali ; He, Yao</creatorcontrib><description>Summary Background &amp; aims Previous epidemiological studies have provided inconsistent conclusions on the impact of coffee consumption in the developing of cognitive disorders. However, no previous meta-analysis has pooled the evidence from the prospective cohort studies to assess the influence of coffee drinking and its potential dose–response patterns on the risk of developing cognitive disorders specifically. Methods Two databases (PubMed and Embase) were searched for evidence of cohort studies from inception to February 2016. We used a generic inverse-variance method with a random-effects model to pool the fully adjusted relative risks (RRs) and the corresponding 95% confidence intervals (CIs). In the dose–response analyses, a generalized least-squares trend estimation model was applied to computing the study-specific slopes. Results Nine prospective cohort studies involving 34,282 participants were included in our study. The duration of follow-up years ranged from 1.3 to 28. Compared with &lt;1 cup, daily drinking of 1–2 cups of coffee was inversely linked with the occurrence of cognitive disorders (i.e., Alzheimer's disease, dementia, cognitive decline, and cognitive impairment), and the pooled RR (95% CI) was 0.82 (0.71, 0.94) with evidence of non-significant heterogeneity (I2  = 25%). Non-significant differences were presented for the association between coffee consumption (&gt;3 vs. &lt;1 cup/d) and incident cognitive disorders. The dose–response analysis showed a “J-shaped” curve relationship of the risk of developing cognitive disorders with coffee consumption. Conclusions A “J-shaped” association was presented between coffee intake and incident cognitive disorders, with the lowest risk of incident cognitive disorders at a daily consumption level of 1–2 cups of coffee.</description><identifier>ISSN: 0261-5614</identifier><identifier>EISSN: 1532-1983</identifier><identifier>DOI: 10.1016/j.clnu.2016.05.015</identifier><identifier>PMID: 27288328</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer's disease ; Coffee intake ; Cognitive disorders ; Cognitive impairment ; Dementia ; Gastroenterology and Hepatology ; Meta-analysis</subject><ispartof>Clinical nutrition (Edinburgh, Scotland), 2017-06, Vol.36 (3), p.730-736</ispartof><rights>Elsevier Ltd and European Society for Clinical Nutrition and Metabolism</rights><rights>2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism</rights><rights>Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003</citedby><cites>FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27288328$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Sun, Dali</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><title>Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies</title><title>Clinical nutrition (Edinburgh, Scotland)</title><addtitle>Clin Nutr</addtitle><description>Summary Background &amp; aims Previous epidemiological studies have provided inconsistent conclusions on the impact of coffee consumption in the developing of cognitive disorders. However, no previous meta-analysis has pooled the evidence from the prospective cohort studies to assess the influence of coffee drinking and its potential dose–response patterns on the risk of developing cognitive disorders specifically. Methods Two databases (PubMed and Embase) were searched for evidence of cohort studies from inception to February 2016. We used a generic inverse-variance method with a random-effects model to pool the fully adjusted relative risks (RRs) and the corresponding 95% confidence intervals (CIs). In the dose–response analyses, a generalized least-squares trend estimation model was applied to computing the study-specific slopes. Results Nine prospective cohort studies involving 34,282 participants were included in our study. The duration of follow-up years ranged from 1.3 to 28. Compared with &lt;1 cup, daily drinking of 1–2 cups of coffee was inversely linked with the occurrence of cognitive disorders (i.e., Alzheimer's disease, dementia, cognitive decline, and cognitive impairment), and the pooled RR (95% CI) was 0.82 (0.71, 0.94) with evidence of non-significant heterogeneity (I2  = 25%). Non-significant differences were presented for the association between coffee consumption (&gt;3 vs. &lt;1 cup/d) and incident cognitive disorders. The dose–response analysis showed a “J-shaped” curve relationship of the risk of developing cognitive disorders with coffee consumption. Conclusions A “J-shaped” association was presented between coffee intake and incident cognitive disorders, with the lowest risk of incident cognitive disorders at a daily consumption level of 1–2 cups of coffee.</description><subject>Alzheimer's disease</subject><subject>Coffee intake</subject><subject>Cognitive disorders</subject><subject>Cognitive impairment</subject><subject>Dementia</subject><subject>Gastroenterology and Hepatology</subject><subject>Meta-analysis</subject><issn>0261-5614</issn><issn>1532-1983</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc-KFDEQxoMo7rj6Ah4kRy_d5k93JyMiLMP6BxY8qOAtxKTazUxPMqbSC3MR38E39ElMO6sHD-ZSKfi-or5fEfKYs5YzPjzbtm6Kcyvqv2V9y3h_h6x4L0XD11reJSsmBt70A-_OyAPELWOsl0rfJ2dCCa2l0CvybZPGEYCGWOwOqI2eluuldcFDLDQH3NE0Upe-xFDCDVAfMGUPGZ_TC-oTws_vPzLgIUUEuodiGxvtdMSAiy-GCPSQEx7A_ba7dJ1yoVhmHwAfknujnRAe3dZz8vHV5YfNm-bq3eu3m4urxnVKlUaxWodRCblWQsGga287CWDt2iuAHpjurJCdkMvzHSjfs66HDnRNzeQ5eXqaW1f5OgMWsw_oYJpshDSj4VoMig1K6SoVJ6mrW2OG0Rxy2Nt8NJyZhbvZmoW7Wbgb1pvKvZqe3M6fP-_B_7X8AV0FL04CqClvAmSDLkB04EOuZIxP4f_zX_5jd1OIwdlpB0fAbZpzhV5zGBSGmffL5ZfD80Eyzvkn-Qvf_6sR</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Wu, Lei</creator><creator>Sun, Dali</creator><creator>He, Yao</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies</title><author>Wu, Lei ; Sun, Dali ; He, Yao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer's disease</topic><topic>Coffee intake</topic><topic>Cognitive disorders</topic><topic>Cognitive impairment</topic><topic>Dementia</topic><topic>Gastroenterology and Hepatology</topic><topic>Meta-analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Sun, Dali</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nutrition (Edinburgh, Scotland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Lei</au><au>Sun, Dali</au><au>He, Yao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies</atitle><jtitle>Clinical nutrition (Edinburgh, Scotland)</jtitle><addtitle>Clin Nutr</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>36</volume><issue>3</issue><spage>730</spage><epage>736</epage><pages>730-736</pages><issn>0261-5614</issn><eissn>1532-1983</eissn><abstract>Summary Background &amp; aims Previous epidemiological studies have provided inconsistent conclusions on the impact of coffee consumption in the developing of cognitive disorders. However, no previous meta-analysis has pooled the evidence from the prospective cohort studies to assess the influence of coffee drinking and its potential dose–response patterns on the risk of developing cognitive disorders specifically. Methods Two databases (PubMed and Embase) were searched for evidence of cohort studies from inception to February 2016. We used a generic inverse-variance method with a random-effects model to pool the fully adjusted relative risks (RRs) and the corresponding 95% confidence intervals (CIs). In the dose–response analyses, a generalized least-squares trend estimation model was applied to computing the study-specific slopes. Results Nine prospective cohort studies involving 34,282 participants were included in our study. The duration of follow-up years ranged from 1.3 to 28. Compared with &lt;1 cup, daily drinking of 1–2 cups of coffee was inversely linked with the occurrence of cognitive disorders (i.e., Alzheimer's disease, dementia, cognitive decline, and cognitive impairment), and the pooled RR (95% CI) was 0.82 (0.71, 0.94) with evidence of non-significant heterogeneity (I2  = 25%). Non-significant differences were presented for the association between coffee consumption (&gt;3 vs. &lt;1 cup/d) and incident cognitive disorders. The dose–response analysis showed a “J-shaped” curve relationship of the risk of developing cognitive disorders with coffee consumption. Conclusions A “J-shaped” association was presented between coffee intake and incident cognitive disorders, with the lowest risk of incident cognitive disorders at a daily consumption level of 1–2 cups of coffee.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27288328</pmid><doi>10.1016/j.clnu.2016.05.015</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0261-5614
ispartof Clinical nutrition (Edinburgh, Scotland), 2017-06, Vol.36 (3), p.730-736
issn 0261-5614
1532-1983
language eng
recordid cdi_proquest_miscellaneous_1826706778
source ScienceDirect Journals
subjects Alzheimer's disease
Coffee intake
Cognitive disorders
Cognitive impairment
Dementia
Gastroenterology and Hepatology
Meta-analysis
title Coffee intake and the incident risk of cognitive disorders: A dose–response meta-analysis of nine prospective cohort studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A26%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coffee%20intake%20and%20the%20incident%20risk%20of%20cognitive%20disorders:%20A%20dose%E2%80%93response%20meta-analysis%20of%20nine%20prospective%20cohort%20studies&rft.jtitle=Clinical%20nutrition%20(Edinburgh,%20Scotland)&rft.au=Wu,%20Lei&rft.date=2017-06-01&rft.volume=36&rft.issue=3&rft.spage=730&rft.epage=736&rft.pages=730-736&rft.issn=0261-5614&rft.eissn=1532-1983&rft_id=info:doi/10.1016/j.clnu.2016.05.015&rft_dat=%3Cproquest_cross%3E1826706778%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-70c476f7239727e680c4a43eeaa9d7ee5e084a234233333d4e7d5045e4e800003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1826706778&rft_id=info:pmid/27288328&rfr_iscdi=true